The role of monoclonal antibody in combination with first-line chemotherapy in Asian patients with advanced non-small cell lung cancer.

Yonsei Med J · 2010 · PMC2799980 · PMID 20046507

Europe PMC DOI

hedged sentence

0.1700

closest p · 3.4× alpha

0.1700

boldest claim

The sentences

did not reach statistical significancep = 0.17not close (p > 0.1)

8.4 months for the control arm, although it did not reach statistical significance (HR, 0.89, 95% CI, 0.754-1.051; p = 0.17).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.